Genome-Wide Analysis of Menin Binding Provides Insights into MEN1 Tumorigenesis

Multiple endocrine neoplasia type I (MEN1) is a familial cancer syndrome characterized primarily by tumors of multiple endocrine glands. The gene for MEN1 encodes a ubiquitously expressed tumor suppressor protein called menin. Menin was recently shown to interact with several components of a trithorax family histone methyltransferase complex including ASH2, Rbbp5, WDR5, and the leukemia proto-oncoprotein MLL. To elucidate menin's role as a tumor suppressor and gain insights into the endocrine-specific tumor phenotype in MEN1, we mapped the genomic binding sites of menin, MLL1, and Rbbp5, to approximately 20,000 promoters in HeLa S3, HepG2, and pancreatic islet cells using the strategy of chromatin-immunoprecipitation coupled with microarray analysis. We found that menin, MLL1, and Rbbp5 localize to the promoters of thousands of human genes but do not always bind together. These data suggest that menin functions as a general regulator of transcription. We also found that factor occupancy generally correlates with high gene expression but that the loss of menin does not result in significant changes in most transcript levels. One exception is the developmentally programmed transcription factor, HLXB9, which is overexpressed in islets in the absence of menin. Our findings expand the realm of menin-targeted genes several hundred-fold beyond that previously described and provide potential insights to the endocrine tumor bias observed in MEN1 patients.

[1]  F. Collins,et al.  Menin, the product of the MEN1 gene, is a nuclear protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Li,et al.  Persistent expression of Hlxb9 in the pancreatic epithelium impairs pancreatic development. , 2001, Developmental biology.

[3]  P. Scambler,et al.  Mutation analysis and embryonic expression of the HLXB9 Currarino syndrome gene. , 2000, American journal of human genetics.

[4]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Arndt Borkhardt,et al.  Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization , 2004, Molecular and Cellular Biology.

[6]  F. Collins,et al.  Mutations of the MEN1 tumor suppressor gene in pituitary tumors. , 1997, Cancer research.

[7]  F. Collins,et al.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Johansson,et al.  Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13). , 2001, Cancer research.

[9]  H. Drexler,et al.  Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML‐M4 cell line (GDM‐1) , 2005, Genes, chromosomes & cancer.

[10]  G. Kay,et al.  Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. , 2004, Molecular cell.

[11]  S. Scherer,et al.  Involvement of the HLXB9 homeobox gene in Currarino syndrome. , 2000, American journal of human genetics.

[12]  T. Strachan,et al.  Autosomal dominant sacral agenesis: Currarino syndrome , 2000, Journal of medical genetics.

[13]  Nicola J. Rinaldi,et al.  Control of Pancreas and Liver Gene Expression by HNF Transcription Factors , 2004, Science.

[14]  O. Rozenblatt-Rosen,et al.  Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[16]  F. Collins,et al.  Menin molecular interactions: insights into normal functions and tumorigenesis. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  O. Rozenblatt-Rosen,et al.  Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Cleary,et al.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. , 2003, Genes & development.

[19]  T. Volkert,et al.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.

[20]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Kay,et al.  Conditional Inactivation of the Men1 Gene Leads to Pancreatic and Pituitary Tumorigenesis but Does Not Affect Normal Development of These Tissues , 2004, Molecular and Cellular Biology.

[22]  E. Lander,et al.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.

[23]  V. Godfrey,et al.  Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity , 2000, Molecular and Cellular Biology.

[24]  C. Larsson,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Alterations of the MEN1 Gene in Sporadic , 2022 .

[25]  Zhao-Qi Wang,et al.  Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. , 2003, Cancer research.

[26]  F. Collins,et al.  Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. , 1997, Cancer research.

[27]  S. Pfaff,et al.  Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice , 1999, Nature Genetics.

[28]  F. Collins,et al.  Somatic mutation of the MEN1 gene in parathyroid tumours , 1997, Nature Genetics.

[29]  F. Collins,et al.  Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. , 1997, Human molecular genetics.

[30]  D. Hanahan,et al.  Of Mice and MEN1: Insulinomas in a Conditional Mouse Knockout , 2003, Molecular and Cellular Biology.

[31]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[32]  John H Kersey,et al.  Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. , 2004, Blood.

[33]  Silvia Arber,et al.  Requirement for the Homeobox Gene Hb9 in the Consolidation of Motor Neuron Identity , 1999, Neuron.

[34]  Zhao-Qi Wang,et al.  Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. , 2003, Molecular endocrinology.

[35]  D. Kemp,et al.  Minireview: transcriptional regulation in pancreatic development. , 2005, Endocrinology.

[36]  Eric S. Lander,et al.  Genomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse , 2005, Cell.

[37]  W. Herr,et al.  Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression , 2004, Molecular and Cellular Biology.

[38]  F. Collins,et al.  Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1 , 2004, Mammalian Genome.

[39]  S. Arber,et al.  Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9 , 1999, Nature Genetics.

[40]  F. Collins,et al.  Pancreatic Insulinomas in Multiple Endocrine Neoplasia, Type I Knockout Mice Can Develop in the Absence of Chromosome Instability or Microsatellite Instability , 2004, Cancer Research.